A detailed history of Grove Bank & Trust transactions in Becton Dickinson & CO stock. As of the latest transaction made, Grove Bank & Trust holds 33 shares of BDX stock, worth $7,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Holding current value
$7,489
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$221.47 - $242.41 $7,308 - $7,999
33 New
33 $7,000
Q4 2023

Jan 30, 2024

SELL
$232.24 - $267.23 $1,625 - $1,870
-7 Reduced 50.0%
7 $1,000
Q3 2023

Oct 30, 2023

BUY
$254.9 - $283.59 $1,784 - $1,985
7 Added 100.0%
14 $3,000
Q4 2022

Feb 03, 2023

BUY
$218.29 - $256.91 $1,528 - $1,798
7 New
7 $2,000
Q1 2018

May 07, 2018

SELL
$205.46 - $240.27 $31,846 - $37,241
-155 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $28,967 - $30,829
155
155 $30,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.